Australian biotech company Opthea has reported a solid cash position to further advance clinical trials of its lead drug candidate OPT-302 in FY20, as it moves closer to imposing itself on the macular disease market. Read more
A significant Australian study into the effectiveness of Allergan’s Ozurdex implant as a treatment for Diabetic Macular Oedema (DME) has shown positive results consistent with previously published evidence. Read more
Australian scientists have developed the world’s most detailed gene map of the human retina, providing new and unprecedented insights into the underlying determinants of retinal cell function. Read more
A new research project examining the proteins that circulate in the eye’s fluids has the potential to pave the way for a test to diagnose glaucoma that doesn’t rely on intraocular pressure.
US biomedical researchers have developed a self-clearing glaucoma drainage device that uses vibration technology to disperse harmful micro-organisms. Read more